CYTIVA SWEDEN AB — TTAB Proceedings
CYTIVA SWEDEN AB is a party to 4 TTAB proceedings.
Proceedings
- Proceeding 90898404 — Ex Parte Appeal, Terminated (filed 2022-12-12) as plaintiff
- Proceeding 91287745 — Oppositions, Terminated (filed 2023-10-18) against Unicorn Pharmaceuticals, Inc. as plaintiff
- Proceeding 97251410 — Extensions of Time to Oppose, Terminated (filed 2023-07-19) against Unicorn Pharmaceuticals, Inc. as plaintiff
- Proceeding 92076157 — Cancellations, Terminated (filed 2020-12-30) against akta Pharmaceutical Development LLC as plaintiff
Marks in These TTAB Matters
Recent Live Filings
- UNIFLUX — Registered, filed 2022-11-09
- GFX — Registered, filed 2022-04-05
- BIACORE INTELLIGENT ANALYSIS — Registered, filed 2021-12-10
- ÄKTA OLIGOSYNT — Registered, filed 2021-10-14
- ÄKTA PROCESS — Registered, filed 2021-10-13
- ÄKTA FLUX — Registered, filed 2021-09-25
- ÄKTA START — Registered, filed 2021-09-25
- ÄKTA READYFLUX — Registered, filed 2021-09-25
- ÄKTA GO — Registered, filed 2021-09-25
- ÄKTA READY — Registered, filed 2021-09-25
- ÄKTA PCC — Registered, filed 2021-09-25
- BIACORE — Registered, filed 2021-03-24
- PDCENTRAL — Registered, filed 2020-12-17
- AKTA PURE — Registered, filed 2020-12-02
- DIBE — Registered, filed 2018-08-17
Common TTAB Counterparties
- Unicorn Pharmaceuticals, Inc. — 2 proceedings
- akta Pharmaceutical Development LLC — 1 proceedings
Recent TTAB Timeline
- 2024-04-22: 90898404 — TERMINATED
- 2024-02-05: 90898404 — BOARD'S DECISION: AFFIRMED
- 2024-01-17: 91287745 — TERMINATED involving Unicorn Pharmaceuticals, Inc.
- 2024-01-17: 91287745 — BOARD'S DECISION: SUSTAINED involving Unicorn Pharmaceuticals, Inc.
- 2023-12-08: 91287745 — NOTICE OF DEFAULT involving Unicorn Pharmaceuticals, Inc.
- 2023-10-18: 91287745 — PENDING, INSTITUTED involving Unicorn Pharmaceuticals, Inc.
- 2023-10-18: 91287745 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Unicorn Pharmaceuticals, Inc.
- 2023-10-18: 91287745 — FILED AND FEE involving Unicorn Pharmaceuticals, Inc.
- 2023-10-16: 90898404 — SUBMITTED ON BRIEF
- 2023-10-04: 90898404 — MEMO FORWARDING REPLY BRIEF
- 2023-09-27: 90898404 — REPLY BRIEF
- 2023-09-07: 90898404 — EXAMINER'S STATEMENT
- 2023-07-19: 97251410 — EXTENSION OF TIME GRANTED involving Unicorn Pharmaceuticals, Inc.
- 2023-07-19: 97251410 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Unicorn Pharmaceuticals, Inc.
- 2023-07-17: 90898404 — APPEAL FORWARDED TO EXAMINER FOR BRIEF
- 2023-07-07: 90898404 — APPEAL BRIEF
- 2023-05-12: 90898404 — PROCEEDINGS RESUMED
- 2023-05-09: 90898404 — SUBSEQUENT FINAL
- 2022-12-12: 90898404 — PENDING, INSTITUTED
- 2022-12-12: 90898404 — APPEAL ACKNOWLEDGED; CASE REMANDED
- 2022-12-12: 90898404 — APPEAL TO BOARD
- 2021-04-08: 92076157 — TERMINATED involving akta Pharmaceutical Development LLC
- 2021-04-08: 92076157 — COMMR ORDER CANCELLING REG involving akta Pharmaceutical Development LLC
- 2021-04-08: 92076157 — BOARD'S DECISION: GRANTED involving akta Pharmaceutical Development LLC
- 2021-02-26: 92076157 — NOTICE OF DEFAULT involving akta Pharmaceutical Development LLC
- 2021-01-07: 92076157 — PENDING, INSTITUTED involving akta Pharmaceutical Development LLC
- 2021-01-07: 92076157 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving akta Pharmaceutical Development LLC
- 2020-12-30: 92076157 — FILED AND FEE involving akta Pharmaceutical Development LLC